Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-7-16
pubmed:abstractText
In a systematic effort to develop a microbicide contraceptive capable of preventing transmission of human immunodeficiency virus (HIV), as well as providing fertility control, we have previously identified novel phenyl phosphate derivatives of zidovudine (ZDV) with 5-halo 6-alkoxy substitutions in the thymine ring and halo substitution in the phenyl moiety respectively. Here, we describe the synthesis, characterization, and successful preclinical formulation of our lead compound, 5-bromo-6-methoxy-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), which exhibits potent anti-HIV and sperm immobilizing activities. The anti-HIV activity of WHI-07 was tested by measuring viral p24 antigen production and reverse transcriptase activity as markers of viral replication in HIV-1 infected human peripheral blood mononuclear cells (PBMC). WHI-07 inhibited replication of HIV in a concentration-dependent fashion with nanomolar IC50 values. The effects of WHI-07 on human sperm motion kinematics were analysed by computer-assisted sperm analysis (CASA), and its effects on sperm membrane integrity were examined by confocal laser scanning microscopy (CLSM), and high-resolution low-voltage scanning electron microscopy (HR-LVSEM). WHI-07 caused cessation of sperm motility in a concentration- and time-dependent fashion. The in-vitro cytotoxicities of WHI-07 and nonoxynol-9 (N-9) were compared using normal human ectocervical and endocervical epithelial cells by the MTT cell viability assay. Unlike N-9, WHI-07 had no effect upon sperm plasma and acrosomal membrane integrity. N-9 was cytotoxic to normal human ectocervical and endocervical cells at spermicidal doses, whereas WHI-07 was selectively spermicidal. The in-vivo vaginal absorption and vaginal toxicity of 2% gel-microemulsion of WHI-07 was studied in the rabbit model. The sperm immobilizing activity of WHI-07 was 18-fold more potent than that of N-9. Over a 10 day period, there was no irritation or local toxicity to the vaginal epithelia or systemic absorption of WHI-07. Therefore, as a potent anti-HIV agent with spermicidal activity, and lack of mucosal toxicity, WHI-07 may have the clinical potential to become the active ingredient of a vaginal contraceptive for women who are at high risk for acquiring HIV by heterosexual vaginal transmission.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1360-9947
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
421-32
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10338365-Acrosome Reaction, pubmed-meshheading:10338365-Animals, pubmed-meshheading:10338365-Anti-HIV Agents, pubmed-meshheading:10338365-Cell Membrane, pubmed-meshheading:10338365-Cervix Uteri, pubmed-meshheading:10338365-Dideoxynucleotides, pubmed-meshheading:10338365-Drug Evaluation, Preclinical, pubmed-meshheading:10338365-Emulsions, pubmed-meshheading:10338365-Epithelial Cells, pubmed-meshheading:10338365-Female, pubmed-meshheading:10338365-HIV-1, pubmed-meshheading:10338365-Humans, pubmed-meshheading:10338365-Male, pubmed-meshheading:10338365-Rabbits, pubmed-meshheading:10338365-Sperm Motility, pubmed-meshheading:10338365-Spermatocidal Agents, pubmed-meshheading:10338365-Spermatozoa, pubmed-meshheading:10338365-Thymidine Monophosphate, pubmed-meshheading:10338365-Vagina, pubmed-meshheading:10338365-Virus Replication, pubmed-meshheading:10338365-Zidovudine
pubmed:year
1999
pubmed:articleTitle
Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities.
pubmed:affiliation
Department of Reproductive Biology, Hughes Institute, St Paul, MN 55113, USA.
pubmed:publicationType
Journal Article